Nameer Ascandar: Outcomes After GI Bleeding in Patients with Rheumatoid Arthritis and AF on Long-Term Oral Anticoagulation
Nameer Ascandar, Internal Medicine Resident Physician at HCA Florida Sarasota Doctors Hospital, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Excited to share our second publication of the month!
This study examined outcomes after gastrointestinal bleeding in patients with rheumatoid arthritis and atrial fibrillation on long-term oral anticoagulation.
We found that patients with rheumatoid arthritis hospitalized for GI bleeding while on anticoagulation for atrial fibrillation had significantly worse in-hospital outcomes, including higher mortality and greater risk of septic shock compared to those without RA.
Interestingly, RA patients had lower rates of acute ischemic stroke and reduced need for blood transfusion, highlighting the complex balance between thrombosis and bleeding in this population.”
Title: Predictors of Mortality and In-Hospital Outcomes After Gastrointestinal Bleed in Patients With Rheumatoid Arthritis and Atrial Fibrillation on Long Term Oral Anticoagulants: A Propensity Score Matched Analysis
Authors: Nameer Ascandar, Abhinav Singh, Ian Lancaster, Shaival Thakore, Michael Schandorf-Lartey, Jeffrey P. Steinhoff
Read the Full Article on Cardiology in Review
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 16, 2026, 17:42Mohamed Sherif Salem: Turning 2026 KDIGO Complexity into Bedside Clarity
-
Mar 16, 2026, 17:39Julie Cardoso: What Happens to Venous Valves When a Blood Clot Forms?
-
Mar 16, 2026, 17:38Nasir Jamal: Blood Transfusion Criteria and Hemodialysis Thresholds in ESRD Patients
-
Mar 16, 2026, 17:37Octavio Cosín Sales: Understanding the Influence of Systemic Factors on Chronic Venous Insufficiency
-
Mar 16, 2026, 17:35Shiny K. Kajal: From Simple Calcium Chelation to Full-Blown Red Cell Metabolic Engineering
-
Mar 16, 2026, 17:12Cold-Stored vs Room-Temperature Platelets in Trauma-Induced Coagulopathy – JTH
-
Mar 16, 2026, 17:10Arturo Cesaro: First Meta-Analysis on the Vascular Protective Role of Semaglutide in PAD
-
Mar 16, 2026, 17:01Jeff Sternlicht: The Most Powerful Time to Lower Cholesterol Is Before Anyone Thinks You Need It
-
Mar 16, 2026, 16:14Siobhan Calafiore: Clinical Advantages of Apixaban Over Rivaroxaban in Reducing Bleeding Risk